The Mesoblast CAR-MSC technology acquisition marks a strategic expansion of its advanced cell therapy platform. The company secured exclusive global rights to a patented chimeric antigen receptor (CAR) system designed to enhance mesenchymal stromal cell (MSC) therapies. Consequently, this move aims to improve treatment precision and therapeutic efficacy across...
Kornit Digital acquires PrintFactory to strengthen its platform strategy and accelerate the shift toward digital, on-demand textile manufacturing. The...
Introduction to PonyWorld 2.0 Autonomous Driving
PonyWorld 2.0 autonomous driving marks a significant evolution in the development of self-improving AI...
Rocket Lab at-the-market offering completion marks a significant capital-raising milestone for the aerospace company. The programme generated substantial proceeds...